MyChesCo on MSN21h
Palvella Therapeutics Expands Phase 3 Trial to Younger PatientsWAYNE, PA — Palvella Therapeutics, Inc. (Nasdaq: PVLA) announced the expansion of SELVA, its Phase 3 clinical trial of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback